GROUP ONE TRADING, L.P. - 4D MOLECULAR THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

4D MOLECULAR THERAPEUTICS IN's ticker is and the CUSIP is 35104E900. A total of 4 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$1,273
-98.2%
100
-97.5%
0.00%–
Q2 2023$72,280
+162.8%
4,000
+150.0%
0.00%–
Q1 2023$27,504
-46.2%
1,600
-30.4%
0.00%–
Q4 2022$51,083
+467.6%
2,300
+475.0%
0.00%–
Q4 2021$9,000–400–0.00%–
 Download
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q1 2023
NameSharesValueWeighting ↓
JANE STREET GROUP, LLC 20,700$355,8330.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 1,600$27,5040.00%
SIMPLEX TRADING, LLC 10,700$1830.00%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders